Maintenance DFMO Increases Survival in High Risk Neuroblastoma

2023-08-24T10:15:19-04:00September 27th, 2018|

Giselle L. Saulnier Sholler, William Ferguson, Genevieve Bergendahl, Jeffrey P. Bond, Kathleen Neville, Don Eslin, Valerie Brown, William Roberts, Randal K. Wada, Javier Oesterheld, Deanna Mitchell, Jessica Foley, Nehal S. Parikh, Francis Eshun, Peter Zage, Jawhar Rawwas, Susan Sencer, Debra Pankiewicz, Monique Quinn, Maria Rich, Joseph Junewick, Jacqueline M. Kraveka, Maintenance DFMO Increases Survival in High [...]

Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses

2023-08-24T10:28:33-04:00September 14th, 2018|

Shukla GS, Sun YJ, Pero SC, Sholler GS, Krag DN. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses.  J Immunol Methods. 2018 Sep;460:51-62

Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

2023-08-24T10:35:17-04:00September 25th, 2017|

Cornelius A, Foley J, Bond J, Nagulapally AB, Steinbrecher J, Hendricks WP, Rich M, Yendrembam S, Bergendahl G, Trent JM, Sholler GS, Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma, Front. Pharmacol., Sept 25, 2017, https://doi.org/10.3389/fphar.2017.00652

Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN

2023-08-24T10:38:53-04:00June 8th, 2017|

Rich M, Zhao P, Nagulapally A, Bond J, Saulnier Sholler G. Inhibition of Neuroblastoma Cell Growth by Difluoromethylornithine (DFMO) and Bortezomib through Suppression of LIN28 and MYCN, Journal of Cancer Therapy, June 2017, 8, 561-578

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma

2023-08-24T10:50:47-04:00April 21st, 2017|

Maser T, Rich M, Hayes D, Zhao P, Nagulapally AB, Bond J, Saulnier Sholler G. Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma, Cancer Med. 2017 Apr 21. doi: 10.1002/cam4.1065. [Epub ahead of print]

A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma

2023-08-24T10:54:20-04:00July 31st, 2015|

Mitchell D, Bergendahl G, Ferguson W, Roberts W, Higgins T, Ashikaga T, DeSarno M, Kaplan J, Kraveka J, Eslin D, Werff AV, Hanna GK, Sholler G, A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma, Pediatr Blood Cancer. 2016 Jan;63(1):39-46. doi: [...]

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma

2023-08-24T11:19:07-04:00May 24th, 2015|

Saulnier Sholler G, Gerner EW, Bergendahl G, MacArthur RB, Vander Werff A, Ashikaga T, Bond JP,  Ferguson W, Roberts W, Wada RK, Eslin D, Kraveka JM, Kaplan J, Mitchell D, Parikh NS, Neville K, Sender L, Higgins T, Kawakita M, Hiramatsu K, Moriya S, Bachmann AS, A Phase I Trial of DFMO Targeting Polyamine Addiction in [...]

Go to Top